Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SHERROL REYNOLDS

Eye and Vision Services Providers Optometrist

NPI
1639244437
CMS profile
495436
Location
DAVIE, FL

General Payments · PY2018–2024

$56,883.55

  • Reported across 88 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$4,204.88

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $2,925.00 1
Food and Beverage $811.45 13
Travel and Lodging $468.43 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $3,342.02 6
PY2019 $16,047.38 23
PY2020 $1,053.14 4
PY2021 $5,174.06 13
PY2022 $26,792.17 24
PY2023 $269.90 3
PY2024 $4,204.88 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $27.99 11/23/2024 Food and Beverage Undisputed 01/23/2026 1105941010 CMS
Alcon Vision LLC $139.99 09/17/2024 Food and Beverage Undisputed 01/23/2026 1110701834 CMS
Astellas Pharma Global Development $73.91 07/30/2024 Food and Beverage Undisputed 01/23/2026 1132965359 CMS
Astellas Pharma US Inc $95.21 11/07/2024 Food and Beverage Undisputed 01/23/2026 1139439592 CMS
Genentech USA, Inc. $468.43 09/21/2024 Travel and Lodging Undisputed 01/23/2026 1133112509 CMS
Genentech USA, Inc. $2,925.00 09/21/2024 Consulting Fee Undisputed 01/23/2026 1133112513 CMS
Genentech USA, Inc. $96.21 09/21/2024 Food and Beverage Undisputed 01/23/2026 1133112517 CMS
Genentech USA, Inc. $114.11 09/21/2024 Food and Beverage Undisputed 01/23/2026 1133112521 CMS
Genentech USA, Inc. $69.23 09/21/2024 Food and Beverage Undisputed 01/23/2026 1133112525 CMS
Genentech USA, Inc. $97.31 09/21/2024 Food and Beverage Undisputed 01/23/2026 1133112529 CMS
Harrow Eye, LLC $13.65 03/08/2024 Food and Beverage Undisputed 01/23/2026 1145613278 CMS
Johnson & Johnson Vision Care, Inc. $22.67 07/06/2024 Food and Beverage Undisputed 01/23/2026 1077705768 CMS
Johnson & Johnson Vision Care, Inc. $19.60 08/13/2024 Food and Beverage Undisputed 01/23/2026 1077705921 CMS
Notal Vision, Inc. $20.74 11/14/2024 Food and Beverage Undisputed 01/23/2026 1129482637 CMS
Tarsus Pharmaceuticals, Inc. $20.83 05/18/2024 Food and Beverage Undisputed 01/23/2026 1139127250 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.